[Nuclear magnetic resonance imaging in multiple sclerosis]. 1985

S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013995 Time The dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Effects, Long-Term,Effects, Longterm,Long-Term Effects,Longterm Effects,Effect, Long-Term,Effect, Longterm,Effects, Long Term,Long Term Effects,Long-Term Effect,Longterm Effect

Related Publications

S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
June 1983, Annals of neurology,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
August 1983, Neurologic clinics,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
June 2006, La Revue du praticien,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
November 1981, Lancet (London, England),
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
September 1991, La Revue du praticien,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
June 1986, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
June 2008, Nihon rinsho. Japanese journal of clinical medicine,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
August 1998, Current opinion in neurology,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
March 2000, Pathologie-biologie,
S Kojima, and T Yagishita, and K Hirayama, and H Ikehira, and N Fukuda
January 2005, Reviews in neurological diseases,
Copied contents to your clipboard!